Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma (Q47888135)
Jump to navigation
Jump to search
scientific article published in August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma |
scientific article published in August 2013 |
Statements
1 reference
Phase II study of induction fixed-dose rate gemcitabine and bevacizumab followed by 30 Gy radiotherapy as preoperative treatment for potentially resectable pancreatic adenocarcinoma (English)
1 reference
David L Bartlett
1 reference
Herbert J Zeh
1 reference
Amer H Zureikat
1 reference
George Van Buren
1 reference
Ramesh K Ramanathan
1 reference
Alyssa M Krasinskas
1 reference
Ryan P Smith
1 reference
Gerard J Abood
1 reference
Nathan Bahary
1 reference
Barry C Lembersky
1 reference
Yongli Shuai
1 reference
Douglas M Potter
1 reference
A James Moser
1 reference
1 August 2013
1 reference
1 reference
20
1 reference
12
1 reference
3787-3793
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference